What is Renaissance's earnings per share (EPS)?

Renaissance (RNR) reported diluted earnings per share of $56.03 for fiscal year 2025. This represents a 59.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Renaissance Financials

RNR

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Renaissance (RNR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Neutral

6/9

Renaissance passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.38x

For every $1 of reported earnings, Renaissance generates $1.38 in operating cash flow ($3.7B OCF vs $2.7B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$12.8B

YoY+9.9%

5Y CAGR+20.0%

10Y CAGR+23.8%

Renaissance generated $12.8B in revenue in fiscal year 2025. This represents an increase of 9.9% from the prior year.

EBITDA

N/A

Net Income

$2.7B

YoY+43.4%

5Y CAGR+28.6%

10Y CAGR+20.1%

Renaissance reported $2.7B in net income in fiscal year 2025. This represents an increase of 43.4% from the prior year.

EPS (Diluted)

$56.03

YoY+59.1%

5Y CAGR+29.6%

10Y CAGR+19.7%

Renaissance earned $56.03 per diluted share (EPS) in fiscal year 2025. This represents an increase of 59.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$1.7B

YoY+3.3%

5Y CAGR-0.1%

10Y CAGR+13.1%

Renaissance held $1.7B in cash against $2.3B in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

43M

YoY-11.7%

5Y CAGR-3.0%

10Y CAGR-0.0%

Renaissance had 43M shares outstanding in fiscal year 2025. This represents a decrease of 11.7% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

20.9%

YoY+4.9pp

5Y CAGR+6.1pp

10Y CAGR-7.6pp

Renaissance's net profit margin was 20.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 4.9 percentage points from the prior year.

Return on Equity

23.1%

YoY+5.4pp

5Y CAGR+13.0pp

10Y CAGR+14.0pp

Renaissance's ROE was 23.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 5.4 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$1.6B

YoY+139.9%

5Y CAGR+91.2%

10Y CAGR+19.9%

Renaissance spent $1.6B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 139.9% from the prior year.

Capital Expenditures

N/A

RNR Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$12.8B+9.9%	$11.7B+28.0%	$9.1B+80.5%	$5.1B-4.1%	$5.3B+2.0%	$5.2B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$82.0M-39.2%	$134.8M+5.6%	$127.6M+172.9%	$46.8M+13.7%	$41.2M-57.6%	$97.0M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$120.9M+28.9%	$93.8M+28.1%	$73.2M+51.4%	$48.3M+1.7%	$47.5M-5.8%	$50.5M
Income Tax	$396.3M+1114.7%	$32.6M+106.4%	-$510.1M-764.2%	-$59.0M-453.2%	-$10.7M-472.7%	$2.9M
Net Income	$2.7B+43.4%	$1.9B-27.0%	$2.6B+341.3%	-$1.1B-2542.8%	-$40.2M-105.3%	$762.4M
EPS (Diluted)	$56.03+59.1%	$35.21-32.6%	$52.27+305.0%	$-25.50-1524.2%	$-1.57-110.3%	$15.31

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$3.0B-7.0%	$3.2B-0.3%	$3.2B-7.6%	$3.5B+51.3%	$2.3B-42.3%	$4.0B+40.5%	$2.8B+8.8%	$2.6B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$12.0M-48.7%	$23.4M-1.5%	$23.8M+4.3%	$22.8M-33.5%	$34.3M+31.5%	$26.1M-25.8%	$35.2M-10.4%	$39.3M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$31.4M+2.6%	$30.6M-3.8%	$31.8M+17.4%	$27.1M+16.5%	$23.2M-2.4%	$23.8M+0.8%	$23.6M+2.2%	$23.1M
Income Tax	$116.1M-22.0%	$148.9M-15.8%	$176.9M+488.5%	-$45.5M+28.8%	-$63.9M-162.6%	$102.0M+589.3%	-$20.8M-235.6%	$15.4M
Net Income	$760.5M-17.0%	$916.5M+9.7%	$835.4M+391.4%	$170.0M+189.6%	-$189.7M-116.0%	$1.2B+134.7%	$503.9M+34.9%	$373.6M
EPS (Diluted)	N/A	$19.40+12.8%	$17.20+426.0%	$3.27	N/A	$22.62+140.4%	$9.41+35.6%	$6.94

RNR Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$53.8B+6.1%	$50.7B+3.5%	$49.0B+34.1%	$36.6B+7.6%	$34.0B+10.2%	$30.8B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$1.7B+3.3%	$1.7B-10.7%	$1.9B+57.2%	$1.2B-35.8%	$1.9B+7.0%	$1.7B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$34.6B+4.3%	$33.2B-0.9%	$33.5B+25.3%	$26.7B+12.2%	$23.8B+19.7%	$19.9B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$2.3B+23.5%	$1.9B-3.7%	$2.0B+67.3%	$1.2B+0.2%	$1.2B+2.8%	$1.1B
Total Equity	$11.6B+9.8%	$10.6B+11.8%	$9.5B+77.5%	$5.3B-19.6%	$6.6B-12.4%	$7.6B
Retained Earnings	$10.8B+30.8%	$8.3B+26.9%	$6.5B+60.2%	$4.1B-22.2%	$5.2B-2.6%	$5.4B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$53.8B-1.3%	$54.5B-0.4%	$54.7B+2.0%	$53.6B+5.8%	$50.7B-3.9%	$52.8B+2.3%	$51.6B+1.2%	$50.9B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$1.7B+1.7%	$1.7B+19.1%	$1.4B-12.5%	$1.6B-2.6%	$1.7B+6.6%	$1.6B-3.3%	$1.6B+1.3%	$1.6B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$34.6B-2.6%	$35.5B-3.7%	$36.9B+0.8%	$36.6B+10.4%	$33.2B-4.3%	$34.7B-1.1%	$35.1B+0.6%	$34.9B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$2.3B+4.5%	$2.2B-1.5%	$2.3B-17.8%	$2.8B+46.0%	$1.9B-2.5%	$1.9B-1.2%	$2.0B+4.0%	$1.9B
Total Equity	$11.6B+0.9%	$11.5B+6.5%	$10.8B+4.4%	$10.3B-2.1%	$10.6B-5.9%	$11.2B+10.4%	$10.2B+3.9%	$9.8B
Retained Earnings	$10.8B+7.1%	$10.1B+9.6%	$9.2B+9.6%	$8.4B+1.7%	$8.3B-2.6%	$8.5B+15.7%	$7.3B+6.9%	$6.9B

RNR Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$3.7B-11.3%	$4.2B+117.9%	$1.9B+19.2%	$1.6B+29.9%	$1.2B-38.0%	$2.0B
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$2.2B+27.6%	-$3.1B+19.9%	-$3.8B-26.7%	-$3.0B-269.5%	-$816.3M+64.6%	-$2.3B
Financing Cash Flow	-$1.4B-9.6%	-$1.3B-149.7%	$2.6B+256.9%	$725.3M+339.8%	-$302.5M-145.5%	$665.2M
Dividends Paid	$74.8M-7.4%	$80.8M+7.6%	$75.1M+16.1%	$64.7M-4.6%	$67.8M-1.0%	$68.5M
Share Buybacks	$1.6B+139.9%	$666.9M	$0-100.0%	$166.7M-83.8%	$1.0B+1540.8%	$62.6M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$483.0M-69.5%	$1.6B+7.7%	$1.5B+831.4%	$157.8M-79.7%	$778.9M-47.7%	$1.5B+22.9%	$1.2B+77.4%	$683.5M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$84.6M+108.1%	-$1.0B-39.8%	-$751.1M-50.4%	-$499.4M-78.2%	-$280.3M+81.3%	-$1.5B-52.9%	-$979.2M-221.6%	-$304.4M
Financing Cash Flow	-$522.3M-100.1%	-$261.0M+71.5%	-$917.5M-416.0%	$290.4M+177.2%	-$376.0M-551.1%	-$57.8M+72.4%	-$209.2M+67.5%	-$644.6M
Dividends Paid	$17.6M-5.2%	$18.5M-3.3%	$19.2M-1.8%	$19.5M-2.1%	$20.0M-0.2%	$20.0M-2.0%	$20.4M-0.5%	$20.5M
Share Buybacks	$660.0M+216.9%	$208.3M-44.3%	$373.6M+4.5%	$357.7M-20.8%	$451.6M+323.0%	$106.8M-1.6%	$108.5M	$0

RNR Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	20.9%+4.9pp	16.0%-12.0pp	28.0%+49.0pp	-21.0%-20.2pp	-0.8%-15.5pp	14.7%
Return on Equity	23.1%+5.4pp	17.7%-9.4pp	27.1%+47.0pp	-19.9%-19.3pp	-0.6%-10.7pp	10.1%
Return on Assets	5.0%+1.3pp	3.7%-1.5pp	5.2%+8.1pp	-2.9%-2.8pp	-0.1%-2.6pp	2.5%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.20+0.0	0.18-0.0	0.21-0.0	0.22+0.0	0.18+0.0	0.15
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	25.6%-3.1pp	28.7%+2.6pp	26.1%+21.2pp	4.9%+13.2pp	-8.3%-38.0pp	29.8%+11.9pp	17.8%+3.4pp	14.4%
Return on Equity	6.6%-1.4pp	8.0%+0.2pp	7.7%+6.1pp	1.6%+3.4pp	-1.8%-12.3pp	10.5%+5.6pp	5.0%+1.1pp	3.8%
Return on Assets	1.4%-0.3pp	1.7%+0.1pp	1.5%+1.2pp	0.3%+0.7pp	-0.4%-2.6pp	2.2%+1.3pp	1.0%+0.2pp	0.7%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.200.0	0.19-0.0	0.21-0.1	0.27+0.1	0.180.0	0.17-0.0	0.190.0	0.19
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Everest Re Gp EG

$13.2B

Reinsurance Grp RGA

$13.5B

Hamilton Insurance Group HG

$3.0B

Siriuspoint Ltd SPNT

$2.6B

Globe Life Inc GL

$11.2B

Frequently Asked Questions

What is Renaissance's annual revenue?

Renaissance (RNR) reported $12.8B in total revenue for fiscal year 2025. This represents a 9.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Renaissance's revenue growing?

Renaissance (RNR) revenue grew by 9.9% year-over-year, from $11.7B to $12.8B in fiscal year 2025.

Is Renaissance profitable?

Yes, Renaissance (RNR) reported a net income of $2.7B in fiscal year 2025, with a net profit margin of 20.9%.

How much debt does Renaissance have?

As of fiscal year 2025, Renaissance (RNR) had $1.7B in cash and equivalents against $2.3B in long-term debt.

What is Renaissance's net profit margin?

Renaissance (RNR) had a net profit margin of 20.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Renaissance's return on equity (ROE)?

Renaissance (RNR) has a return on equity of 23.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Renaissance's operating cash flow?

Renaissance (RNR) generated $3.7B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Renaissance's total assets?

Renaissance (RNR) had $53.8B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Renaissance buy back shares?

Yes, Renaissance (RNR) spent $1.6B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Renaissance have outstanding?

Renaissance (RNR) had 43M shares outstanding as of fiscal year 2025.

What is Renaissance's debt-to-equity ratio?

Renaissance (RNR) had a debt-to-equity ratio of 0.20 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Renaissance's return on assets (ROA)?

Renaissance (RNR) had a return on assets of 5.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Renaissance's Piotroski F-Score?

Renaissance (RNR) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Renaissance's earnings high quality?

Renaissance (RNR) has an earnings quality ratio of 1.38x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.